Xuefang Dong

451 citations
29 papers · 378 indexed · h-index 11
Topics
Glycosylation and Glycoproteins Research (15 papers)Analytical Chemistry and Chromatography (6 papers)Monoclonal and Polyclonal Antibodies Research (6 papers)
Partner nations
ChinaBulgariaMongolia

In The Last Decade

Xuefang Dong

26 papers receiving 376 citations

Peers

Xuefang Dong
Comparison fields: 5 of 61
  • Spectroscopy 192
  • Molecular Biology 179
  • Biomedical Engineering 129
  • Analytical Chemistry 86
  • Materials Chemistry 65
Replace Xiaodong Bi with:
Xiaodong Bi China
Canan Armutçu Türkiye
Jens Sproß Germany
Xueying Liu China
Marta Rodriguez-Aller Switzerland
Hong Ding China
Huijuan Yan China
Mashaalah Zarejousheghani Germany
Ming-Luan Chen China
Eva M. Brun Spain
Xuefang Dong relative to Xiaodong Bi China Xiaodong Bi's profile →
Citations per field
00.5×1.6×
Xiaodong Bi · 1×
Citations per year

Countries citing papers authored by Xuefang Dong

Since Specialization
Citations

This map shows the geographic impact of Xuefang Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuefang Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuefang Dong more than expected).

Fields of papers citing papers by Xuefang Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuefang Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuefang Dong. The network helps show where Xuefang Dong may publish in the future.

Co-authorship network of co-authors of Xuefang Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Xuefang Dong. A scholar is included among the top collaborators of Xuefang Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuefang Dong. Xuefang Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 0
4 1
5 0
6 2
7 7
8 5
9 3
10 6
11 6
12 4
13 12
14 51
15 41
16 9
17 10
18 1
19 75
20 19

About Xuefang Dong

Xuefang Dong is a scholar working on Spectroscopy, Molecular Biology and Analytical Chemistry, having authored 29 papers that have together received 378 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (15 papers), Analytical Chemistry and Chromatography (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). The work is most often cited by research in Spectroscopy (192 citations), Analytical Chemistry (86 citations) and Biomedical Engineering (129 citations). Xuefang Dong has collaborated with scholars based in China, Bulgaria and Mongolia. Frequent co-authors include Aijin Shen, Zhimou Guo, Xinmiao Liang, Xinmiao Liang, Xiuling Li, Jie Wei, Xiuling Li, Jingyu Yan, Hong Ma and Zhimou Guo. Their work appears in journals such as ACS Nano, Analytical Chemistry and ACS Applied Materials & Interfaces.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026